tenofovir has been researched along with Sexually Transmitted Diseases in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 6 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Baum, MM; Clark, MR; Moss, JA; Nuttall, J; Palanee-Phillips, T; Romano, JW | 1 |
| Donald, JL; Gift, TL; Salas, SB; Schmidt, MA; Tao, G | 1 |
| Ando, N; Aoki, T; Gatanaga, H; Kikuchi, Y; Mizushima, D; Oka, S; Takano, M; Uemura, H; Watanabe, K; Yanagawa, Y | 1 |
| Bedoya, LM; Cazorla-Luna, R; Martín-Illana, A; Notario-Pérez, F; Peña, J; Ruiz-Caro, R; Veiga, MD | 1 |
| Amin, J; Bavinton, B; Cabrera Quichua, G; Grulich, AE; Guy, R; Holden, J; Jin, F; McManus, H; McNulty, A; Ogilvie, E; Price, K; Selvey, C; Smith, D; Vaccher, S; Vickers, T; Yeung, B; Zablotska, I | 1 |
| Anderson, M; Andrew, P; Baepanye, K; Burns, D; Cohen, MS; Corey, L; Donnell, D; Edupuganti, S; Garnett, P; Gomez Lorenzo, MM; Greene, E; Hural, J; Juraska, M; Karg, C; Karuna, S; Kochar, N; Lazarus, E; Ledgerwood, J; Luthuli, N; Marshall, K; Mascola, JR; Mgodi, NM; Miner, MD; Mukwekwerere, PG; Rudnicki, E; Shava, E; Takuva, S; Tindale, I | 1 |
| Mwethera, PG; Obiero, J; Ogongo, P; Wiysonge, CS | 1 |
| Armishaw, J; Asselin, J; Batrouney, C; Chang, CC; Cornelisse, VJ; Cundill, P; El-Hayek, C; Fairley, CK; Forgan-Smith, G; Gall, J; Hellard, ME; Hoy, JF; Lal, L; Lockwood, JT; Mak, A; Murphy, DA; Nguyen, L; Penn, M; Pickett, C; Price, B; Roth, NJ; Ruth, S; Ryan, KE; Spelman, TD; Stoové, MA; Tee, BK; Traeger, MW; Vujovic, O; West, M; Willcox, J; Wright, EJ | 1 |
| Hedrick, JL; Ke, X; Lee, AL; Ng, VW; Poon, GL; Yang, YY | 1 |
| Aboulker, JP; Capitant, C; Charbonneau, P; Charreau, I; Chas, J; Cheret, A; Chidiac, C; Cotte, L; Cua, E; Delaugerre, C; Delfraissy, JF; Doré, V; Etien, N; Fonsart, J; Girard, G; Le Gall, JM; Lorente, N; Loze, B; Marchand, L; Meyer, L; Molina, JM; Pasquet, A; Peytavin, G; Pialoux, G; Pintado, C; Préau, M; Raffi, F; Rooney, JF; Rozenbaum, W; Simon, MC; Spire, B; Suzan-Monti, M; Thompson, D; Timsit, J; Tremblay, C; Wainberg, MA | 1 |
| Brand, RM; Carballo-Diéguez, A; Cranston, RD; Dolezal, C; Duffill, K; Engstrom, JC; Febo, I; Frasca, T; Giguere, R; Jacobson, C; Leu, CS; Mayer, KH; McGowan, I; Nikiforov, A; Park, SY; Schwartz, JL; Siegel, A | 1 |
| Bedoya, LM; Cazorla-Luna, R; Martín-Illana, A; Notario-Pérez, F; Rubio, J; Ruiz-Caro, R; Tamayo, A; Veiga, MD | 1 |
| Hogben, M; Liddon, N | 1 |
| Mwethera, PG; Obiero, J; Wiysonge, CS | 1 |
| Thompson, M | 1 |
| Balán, IC; Carballo-Diéguez, A; El-Sadr, W; Gai, F; Hoffman, S; Mantell, JE; Maslankowski, L; Mayer, K; Morrow, K; Rosen, R | 1 |
3 review(s) available for tenofovir and Sexually Transmitted Diseases
| Article | Year |
|---|---|
Drug-releasing vaginal rings for HIV/STI and pregnancy prevention: a review of recent advances and clinical applications.
Topics: Adolescent; Contraceptive Devices, Female; Female; HIV Infections; Humans; Pharmaceutical Preparations; Pregnancy; Sexually Transmitted Diseases; Tenofovir | 2022 |
Topical microbicides for preventing sexually transmitted infections.
Topics: Acrylic Resins; Adenine; Administration, Intravaginal; Agaricales; Anti-HIV Agents; Anti-Infective Agents, Local; Bias; Cellulose; Female; HIV Infections; Humans; Naphthalenesulfonates; Placebos; Polymers; Pyrimidines; Seaweed; Sexually Transmitted Diseases; Tenofovir | 2021 |
Topical microbicides for prevention of sexually transmitted infections.
Topics: Acrylic Resins; Adenine; Administration, Topical; Agaricales; Anti-HIV Agents; Anti-Infective Agents, Local; Cellulose; Female; HIV Infections; Humans; Male; Naphthalenesulfonates; Organophosphonates; Polymers; Seaweed; Sexually Transmitted Diseases; Tenofovir | 2012 |
4 trial(s) available for tenofovir and Sexually Transmitted Diseases
| Article | Year |
|---|---|
A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings.
Topics: Adolescent; Adult; AIDS Vaccines; Antibodies, Monoclonal; Botswana; Broadly Neutralizing Antibodies; Chlamydia; Chlamydia Infections; Contraception; Double-Blind Method; Female; Gonorrhea; HIV Antibodies; HIV Infections; HIV-1; Humans; Incidence; Kenya; Malawi; Middle Aged; Mozambique; Prevalence; Sexually Transmitted Diseases; South Africa; Syphilis; Tenofovir; Trichomonas; Trichomonas Infections; Young Adult | 2021 |
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
Topics: Adult; Condoms; Double-Blind Method; Drug Therapy, Combination; Emtricitabine; HIV Infections; HIV-1; Homosexuality, Male; Humans; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Pre-Exposure Prophylaxis; Risk Factors; Sexual Behavior; Sexually Transmitted Diseases; Tenofovir | 2015 |
Project Gel a Randomized Rectal Microbicide Safety and Acceptability Study in Young Men and Transgender Women.
Topics: Administration, Rectal; Adolescent; Adult; Anti-HIV Agents; Chlamydia Infections; Cross-Sectional Studies; Female; Gels; Herpes Genitalis; HIV Infections; Homosexuality, Male; Humans; Male; Sexually Transmitted Diseases; Tenofovir; Transgender Persons; Young Adult | 2016 |
Acceptability of tenofovir gel as a vaginal microbicide by US male participants in a Phase I clinical trial (HPTN 050).
Topics: Adenine; Administration, Intravaginal; Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Patient Satisfaction; Sexually Transmitted Diseases; Tenofovir; Treatment Outcome; Vaginal Creams, Foams, and Jellies | 2007 |
9 other study(ies) available for tenofovir and Sexually Transmitted Diseases
| Article | Year |
|---|---|
Impact of the Early COVID-19 Pandemic on the Number of HIV Preexposure Prophylaxis Uses and the Proportion of Preexposure Prophylaxis Users Receiving Sexually Transmitted Infection Testing Services.
Topics: COVID-19; Emtricitabine; Gonorrhea; HIV Infections; Homosexuality, Male; Humans; Male; Pandemics; Pre-Exposure Prophylaxis; Retrospective Studies; Sexually Transmitted Diseases; Tenofovir | 2023 |
Effect of tenofovir-based HIV pre-exposure prophylaxis against HBV infection in men who have sex with men.
Topics: Anti-HIV Agents; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Homosexuality, Male; Humans; Male; Pre-Exposure Prophylaxis; Sexual and Gender Minorities; Sexually Transmitted Diseases; Tenofovir | 2023 |
Development of mucoadhesive vaginal films based on HPMC and zein as novel formulations to prevent sexual transmission of HIV.
Topics: Adhesives; Administration, Intravaginal; Animals; Anti-HIV Agents; Cell Line; Chemistry, Pharmaceutical; Drug Liberation; Female; Glycerol; HIV Infections; Humans; Hypromellose Derivatives; Polyethylene Glycols; Polymers; Sexually Transmitted Diseases; Tenofovir; THP-1 Cells; Vagina; Zein | 2019 |
Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men.
Topics: Adult; Anti-HIV Agents; Australia; Cohort Studies; Emtricitabine; Health Risk Behaviors; HIV Infections; Humans; Incidence; Male; Pre-Exposure Prophylaxis; Sexual and Gender Minorities; Sexual Behavior; Sexually Transmitted Diseases; Tenofovir | 2020 |
Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.
Topics: Adolescent; Adult; Anti-HIV Agents; Australia; Bisexuality; Drug Therapy, Combination; Emtricitabine; HIV Infections; Homosexuality, Male; Humans; Incidence; Male; Middle Aged; Population Surveillance; Pre-Exposure Prophylaxis; Proportional Hazards Models; Sexually Transmitted Diseases; Tenofovir; Unsafe Sex; Young Adult | 2019 |
Co-delivery of antiviral and antifungal therapeutics for the treatment of sexually transmitted infections using a moldable, supramolecular hydrogel.
Topics: Animals; Antifungal Agents; Antiviral Agents; Biofilms; Candida albicans; Cells, Cultured; Drug Delivery Systems; Drug Evaluation, Preclinical; Fibroblasts; Humans; Hydrogels; Mice; Microbial Sensitivity Tests; Polycarboxylate Cement; Polyethylene Glycols; Sexually Transmitted Diseases; Sexually Transmitted Diseases, Viral; Tenofovir; Vitamin D | 2015 |
Influence of Chitosan Swelling Behaviour on Controlled Release of Tenofovir from Mucoadhesive Vaginal Systems for Prevention of Sexual Transmission of HIV.
Topics: Acrylic Resins; Adhesives; Animals; Cattle; Cell Line; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Drug Delivery Systems; Female; Galactans; HIV Infections; Humans; Hypromellose Derivatives; Mannans; Mucous Membrane; Plant Gums; Polymers; Sexually Transmitted Diseases; Tablets; Tenofovir; Vagina | 2017 |
Disinhibition and risk compensation: scope, definitions, and perspective.
Topics: Adenine; Anti-HIV Agents; Chemoprevention; Clinical Trials as Topic; Counseling; Female; HIV Infections; Humans; Male; Organophosphonates; Reverse Transcriptase Inhibitors; Risk Reduction Behavior; Safe Sex; Sex Work; Sexual Behavior; Sexually Transmitted Diseases; Tenofovir | 2008 |
The experts speak. Studying the potential of tenofovir to prevent sexual transmission of HIV: first steps. Interview by Vicki Glaser.
Topics: Adenine; Communicable Disease Control; Female; HIV Infections; Humans; Male; Organophosphonates; Primary Prevention; Risk Assessment; Sensitivity and Specificity; Sexually Transmitted Diseases; Tenofovir; Treatment Outcome | 2005 |